Accueil / Communiqués

Communiqués

Business Figures for the First Half of 2017: Sartorius Continues to Grow

Friday, July 21st 2017 at 5:00am UTC Double-digit increases in sales and profit Lab Products & Services develops highly dynamically through organic growth and acquisitions Solid growth of the Bioprocess Solutions Division in an expected normalized market environment Forecast for the full year of 2017 confirmed GOETTINGEN, Germany–(BUSINESS WIRE)– Sartorius …

Plus »

Masimo Anuncia la Marca CE de RPVi™ No Invasivo, un Índice de Variabilidad Pletismográfica de Longitud de Onda Múltiples rainbow®

Friday, July 21st 2017 at 3:54am UTC NEUCHATEL, Suiza–(BUSINESS WIRE)– Masimo (NASDQ: MASI) anunció hoy la marca CE de RPVi™, una medición continua y no invasiva de los cambios dinámicos en el índice de perfusión (Perfusion Index, PI) que se produce durante uno o más ciclos respiratorios. El RPVi está …

Plus »

Insulet prendra en charge la distribution et l’assistance commerciale de son système Omnipod® en Europe

Friday, July 21st 2017 at 2:27am UTC La distribution directe contribue à la solidité et à la croissance de la clientèle européenne et renforce les perspectives financières de la société BILLERICA, Massachusetts–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet ou la Société), le chef de file de la technologie de pompe …

Plus »

GSK Submits EU Filing for Extended Use of Relvar Ellipta in Patients with Controlled Asthma on an ICS/LABA Combination

Friday, July 21st 2017 at 1:00pm UTC LONDON–(BUSINESS WIRE)– GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced a submission to the European Medicines Agency (EMA) for the extended use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI), an inhaled corticosteroid (ICS) / long-acting β2-agonist (LABA) combination, in patients …

Plus »

Tissue Regenix Announces Proposed Acquisition of CellRight Technologies

Friday, July 21st 2017 at 3:07pm UTC Combination dramatically increases Tissue Regenix’s U.S. market presence, expands regenerative medicine capabilities allowing for better patient care SAN ANTONIO–(BUSINESS WIRE)– Tissue Regenix, the UK-based regenerative medical devices company, today announced the proposed acquisition of CellRight Technologies, a U.S. regenerative medicine company based in …

Plus »

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy

Friday, July 21st 2017 at 11:26am UTC Positive opinion based on the results of two randomized Phase 3 trials, TELESTAR and TELECAST PARIS–(BUSINESS WIRE)– Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines …

Plus »

Sage Therapeutics to Report Second Quarter 2017 Financial Results on Thursday, August 3, 2017

Thursday, July 20th 2017 at 8:10pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the company will host a conference call and live webcast on Thursday, August 3, 2017 at 4:30 pm ET …

Plus »

Sunovion’s Latuda® (lurasidone HCI) Receives Health Canada Approval to Treat Adolescents with Schizophrenia

Friday, July 21st 2017 at 3:30pm UTC – Health Canada has also accepted for review a Supplemental New Drug Submission (SNDS) for LATUDA for the treatment of bipolar depression in pediatric patients – MARLBOROUGH, Mass.–(BUSINESS WIRE)– Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Health Canada approved the Supplemental New Drug …

Plus »

Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO

Thursday, July 20th 2017 at 9:00pm UTC CHARLESTON, S.C.–(BUSINESS WIRE)– Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), announced today that it has formed a special committee of independent directors (the “Strategic Review Committee”) to consider and evaluate various strategic and financing alternatives available to the Company to maximize …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...